Data as of 12:43pm ET
| +0.12 / +6.12%|
The 1 analysts offering 12-month price forecasts for PharmAthene Inc have a median target of 8.50, with a high estimate of 8.50 and a low estimate of 8.50. The median estimate represents a +308.65% increase from the last price of 2.08.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.